Incidentaloma screening: Difference between revisions

Jump to navigation Jump to search
Medhat (talk | contribs)
No edit summary
Medhat (talk | contribs)
No edit summary
Line 5: Line 5:
==Overview==
==Overview==


According to the [guideline name], screening for [disease name] is not recommended.
According to the European Society of Endocrinology Clinical Practice Guideline, screening for adrenal incidentaloma includes: family screening for patients  with bilateral macronodular [[hyperplasia]], patients with asymptomatic [[vertebral fractures]], patients with possible autonomous [[cortisol]] secretion, patients with a hereditary syndrome leading to [[Adrenal tumor|adrenal tumors]]. Screening test include 24-hour urine [[Metanephrine|fractionated metanephrines]] for [[pheochromocytoma]], 24-hour urinary free [[cortisol]] for patients with symptoms of [[Cushing's syndrome]], and [[Aldosterone|Plasma aldosterone concentration]], [[plasma renin activity]] for patients with [[Primary hyperaldosteronism|Primary aldosteronism]].
==Screening==
==Screening==
*According to the European Society of Endocrinology Clinical Practice Guideline, screening for adrenal incidentaloma includes:
*According to the European Society of Endocrinology Clinical Practice Guideline, screening for adrenal incidentaloma includes:  


=== Indications for adrenal incidentaloma screening ===
=== Indications for adrenal incidentaloma screening ===
* Patients with possible autonomous cortisol secretion or autonomous cortisol secretion for hypertension and type 2 diabetes mellitus.
* Patients with possible autonomous [[cortisol]] secretion for [[hypertension]] and [[Diabetes mellitus type 2|type 2 diabetes mellitus.]]
* Patients with asymptomatic vertebral fractures.
* Patients with asymptomatic [[vertebral fractures]].
* Screening imaging in patients with a hereditary syndrome leading to adrenal tumors.
* Screening imaging in patients with a hereditary syndrome leading to [[Adrenal tumor|adrenal tumors]].
* Family screening with 1 mg dexamethasone test can be considered in cases of bilateral macronodular hyperplasia, especially in younger patients.
* Family screening with 1 mg [[Dexamethasone suppression test|dexamethasone test]] can be considered in cases of bilateral macronodular [[hyperplasia]], especially in younger patients.


=== Screening measures ===
=== Screening measures ===
Line 20: Line 20:
!Laboratory tests
!Laboratory tests
|-
|-
|Pheochromocytoma
|[[Pheochromocytoma]]
|'''24-hour urine:'''
|'''24-hour urine:'''
Fractionated
* [[Metanephrine|Fractionated metanephrines]]
 
* [[Catecholamines|Fractionated catecholamines]]
metanephrines
 
Fractionated
 
catecholamines
 
'''Blood:'''
'''Blood:'''
 
* [[Metanephrine|Fractionated metanephrines]]
Fractionated
 
metanephrines
|-
|-
|Cushing's
|[[Cushing's syndrome]]
syndrome
|'''For patients with''' '''symptoms of [[Cushing's syndrome|Cushing's]]''' [[Cushing's syndrome|'''syndrome''']]''':'''
|'''For patients with'''
* 24-hour urinary free [[cortisol]]
'''symptoms of Cushing's'''
'''For patients lacking''' '''symptoms of [[Cushing's syndrome|Cushing's]]''' [[Cushing's syndrome|'''syndrome''']]''':'''
 
* 1 mg overnight [[dexamethasone suppression test]]
'''syndrome:'''
 
24-hour urinary free
 
cortisol
 
'''For patients lacking'''
 
'''symptoms of Cushing's'''
 
'''syndrome:'''
 
1 mg overnight
 
dexamethasone
 
suppression test
|-
|-
|Primary
|[[Primary hyperaldosteronism|Primary aldosteronism]]
aldosteronism
|[[Aldosterone|Plasma aldosterone concentration]], [[plasma renin activity]]
|Plasma aldosterone
concentration, plasma
 
renin activity
|}
|}



Revision as of 21:17, 5 September 2017

Incidentaloma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Incidentaloma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Incidentaloma screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Incidentaloma screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Incidentaloma screening

CDC on Incidentaloma screening

Incidentaloma screening in the news

Blogs on Incidentaloma screening

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Incidentaloma screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

According to the European Society of Endocrinology Clinical Practice Guideline, screening for adrenal incidentaloma includes: family screening for patients with bilateral macronodular hyperplasia, patients with asymptomatic vertebral fractures, patients with possible autonomous cortisol secretion, patients with a hereditary syndrome leading to adrenal tumors. Screening test include 24-hour urine fractionated metanephrines for pheochromocytoma, 24-hour urinary free cortisol for patients with symptoms of Cushing's syndrome, and Plasma aldosterone concentration, plasma renin activity for patients with Primary aldosteronism.

Screening

  • According to the European Society of Endocrinology Clinical Practice Guideline, screening for adrenal incidentaloma includes:

Indications for adrenal incidentaloma screening

Screening measures

Disease Laboratory tests
Pheochromocytoma 24-hour urine:

Blood:

Cushing's syndrome For patients with symptoms of Cushing's syndrome:

For patients lacking symptoms of Cushing's syndrome:

Primary aldosteronism Plasma aldosterone concentration, plasma renin activity

References

Template:WH Template:WS